Search
Philip Robinson
The Lancet Respiratory Medicine
2
Role
Title
Level
Year
L/R
🐜
Vanzacaftor-tezacaftor-deutivacaftor for children aged 6-11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial.
18 auth.
J. Hoppe,
Ajay S Kasi,
Jessica E Pittman,
Renee Jensen,
Lena P Thia,
Philip Robinson,
Pornchai Tirakitsoontorn,
Bonnie Ramsey,
M. A. Mall,
J. Taylor-Cousar,
...
E. McKone,
Elizabeth Tullis,
Danieli B Salinas,
Jiaqiang Zhu,
Yih-Chieh Chen,
Violeta Rodriguez-Romero,
P. Sosnay,
Gwyneth Davies
2
2024
2
🐜
